| Market Cap | 3.1B |
| P/E Ratio | - |
| P/B Ratio | - |
| EPS | -0.17 |
| Dividend Yield | - |
| D/E Ratio | 0.18 |
| Current Ratio | 8.31 |
| Market Segment | ChiNext |
| Currency | CNY |
Business Overview
Liaoning He Eye Hospital Group Co., LTD. provides ophthalmic specialist diagnosis, treatment, and optometry services to patients with eye diseases. It offers cataract diagnosis and treatment, refractive error surgical correction, vitreoretinal diagnosis and treatment, other surgical diagnosis and treatment services, etc. The company also provides refractive cataracts, LASIK surgery, myopia prevention, medical fitting, diabetic retinopathy, dry eyes and cornea, gene diagnosis, and comprehensive eye disease solutions. Liaoning He Eye Hospital Group Co., LTD. was founded in 1995 and is based in Shenyang, China.
Key Financial Metrics
Profitability
Returns & Efficiency
Financial Health
| Industry | Healthcare |
| Market Segment | ChiNext |
| Currency | CNY |
| Fiscal Year | 2024 |
Stock Chart
Full charting with technical indicators, candlestick, line charts, and more.
Company Profile
| Company Name | 何氏眼科 |
| Ticker | 301103 |
| Exchange | SZSE |
| Sector | CSRC Classification |
| Industry | Healthcare |
| Market Segment | ChiNext |
| Fiscal Year | 2024 |
| Currency | CNY |
| Market Cap | 3.1B |
| Revenue | 1.1B |
| Net Income | -35.3M |
| P/E Ratio | - |
| EPS | -0.17 |
| Net Margin | -3.2% |
| ROE | -1.9% |
| Dividend Yield | - |
Liaoning He Eye Hospital Group Co., LTD. provides ophthalmic specialist diagnosis, treatment, and optometry services to patients with eye diseases. It offers cataract diagnosis and treatment, refractive error surgical correction, vitreoretinal diagnosis and treatment, other surgical diagnosis and treatment services, etc. The company also provides refractive cataracts, LASIK surgery, myopia prevention, medical fitting, diabetic retinopathy, dry eyes and cornea, gene diagnosis, and comprehensive eye disease solutions. Liaoning He Eye Hospital Group Co., LTD. was founded in 1995 and is based in Shenyang, China.